{"id":"https://openalex.org/W4391476828","doi":"https://doi.org/10.1177/11206721241229912","title":"Long term follow up of patients with MNV3 treated with intra-vitreal Aflibercept","display_name":"Long term follow up of patients with MNV3 treated with intra-vitreal Aflibercept","publication_year":2024,"publication_date":"2024-02-02","ids":{"openalex":"https://openalex.org/W4391476828","doi":"https://doi.org/10.1177/11206721241229912","pmid":"https://pubmed.ncbi.nlm.nih.gov/38304945"},"language":"en","primary_location":{"id":"doi:10.1177/11206721241229912","doi":"https://doi.org/10.1177/11206721241229912","is_oa":false,"landing_page_url":"https://doi.org/10.1177/11206721241229912","pdf_url":null,"source":{"id":"https://openalex.org/S128637052","display_name":"European Journal of Ophthalmology","issn_l":"1120-6721","issn":["1120-6721","1724-6016"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045731399","display_name":"Andrew C. Browning","orcid":"https://orcid.org/0000-0003-1667-8505","observed_orcids":["https://orcid.org/0000-0003-1667-8505"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andrew C Browning","raw_affiliation_strings":["Royal Victoria Infirmary","Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK"],"raw_orcid":"https://orcid.org/0000-0003-1667-8505","affiliations":[{"raw_affiliation_string":"Royal Victoria Infirmary","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078368069","display_name":"Michael E. Grinton","orcid":"https://orcid.org/0000-0001-6284-774X","observed_orcids":["https://orcid.org/0000-0001-6284-774X"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael E Grinton","raw_affiliation_strings":["Royal Victoria Infirmary","Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Victoria Infirmary","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058355457","display_name":"Stephanie A. Quinn","orcid":"https://orcid.org/0000-0002-5422-8647","observed_orcids":["https://orcid.org/0000-0002-5422-8647"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephanie Quinn","raw_affiliation_strings":["Royal Victoria Infirmary","Medical Physics Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Victoria Infirmary","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Medical Physics Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093848694","display_name":"Tania Jain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tania Jain","raw_affiliation_strings":["Royal Victoria Infirmary","Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Victoria Infirmary","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017430389","display_name":"Venughanan Manikavasagar","orcid":"https://orcid.org/0009-0008-5223-5692","observed_orcids":["https://orcid.org/0009-0008-5223-5692"]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Venughanan Manikavasagar","raw_affiliation_strings":["Royal Victoria Infirmary","Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Victoria Infirmary","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035991808","display_name":"Akhunzada Muhammad Aftab","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Akhunzada M Aftab","raw_affiliation_strings":["Royal Victoria Infirmary","Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Victoria Infirmary","institution_ids":["https://openalex.org/I2800516725"]},{"raw_affiliation_string":"Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2800516725"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045731399"],"corresponding_institution_ids":["https://openalex.org/I2800516725"],"apc_list":{"value":3950,"currency":"USD","value_usd":3950},"apc_paid":null,"fwci":0.3598,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.50721252,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"34","issue":"5","first_page":"1562","last_page":"1568"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/retinal-angiomatous-proliferation","display_name":"retinal angiomatous proliferation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9539999961853027},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":0.9539999961853027},{"id":"https://openalex.org/keywords/intravitreal-anti-vegf-therapy","display_name":"intravitreal anti-VEGF therapy","score":0.9100000262260437},{"id":"https://openalex.org/keywords/long-term-visual-outcomes","display_name":"long-term visual outcomes","score":0.8080000281333923},{"id":"https://openalex.org/keywords/central-macular-thickness","display_name":"central macular thickness","score":0.843999981880188},{"id":"https://openalex.org/keywords/visual-acuity-stability","display_name":"visual acuity stability","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.9089082479476929},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7863329648971558},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5212231874465942},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.5136703848838806},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3281313180923462},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1597995162010193},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.0957399308681488},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005451","descriptor_name":"Fluorescein Angiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005654","descriptor_name":"Fundus Oculi","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D041623","descriptor_name":"Tomography, Optical Coherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D057135","descriptor_name":"Wet Macular Degeneration","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/11206721241229912","doi":"https://doi.org/10.1177/11206721241229912","is_oa":false,"landing_page_url":"https://doi.org/10.1177/11206721241229912","pdf_url":null,"source":{"id":"https://openalex.org/S128637052","display_name":"European Journal of Ophthalmology","issn_l":"1120-6721","issn":["1120-6721","1724-6016"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Ophthalmology","raw_type":"journal-article"},{"id":"pmid:38304945","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38304945","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of ophthalmology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2691480339","display_name":"HEE/NIHR ICA Pre-doctoral Clinical and Practitioner Academic Fellowship 2022","funder_award_id":"NIHR302730","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1500728559","https://openalex.org/W1968189763","https://openalex.org/W1988711529","https://openalex.org/W1990850867","https://openalex.org/W2004167950","https://openalex.org/W2068742492","https://openalex.org/W2083043469","https://openalex.org/W2117109937","https://openalex.org/W2123992786","https://openalex.org/W2124415048","https://openalex.org/W2131192872","https://openalex.org/W2154073405","https://openalex.org/W2195866396","https://openalex.org/W2333902875","https://openalex.org/W2343042175","https://openalex.org/W2486869590","https://openalex.org/W2545082692","https://openalex.org/W2589712135","https://openalex.org/W2596687123","https://openalex.org/W2766820003","https://openalex.org/W2914844160","https://openalex.org/W2948088537","https://openalex.org/W2990320714","https://openalex.org/W2991411084","https://openalex.org/W3013512820","https://openalex.org/W3014227577","https://openalex.org/W3045866238","https://openalex.org/W3097660920","https://openalex.org/W4214582981","https://openalex.org/W4250823169","https://openalex.org/W4366742224"],"related_works":["https://openalex.org/W2827990227","https://openalex.org/W2946064166","https://openalex.org/W3041737655","https://openalex.org/W3007502108","https://openalex.org/W4411718856","https://openalex.org/W2616226964","https://openalex.org/W2259286248","https://openalex.org/W1459148225","https://openalex.org/W2112069706","https://openalex.org/W543922"],"abstract_inverted_index":{"PURPOSE:":[0],"MNV3":[1,29,49,231],"or":[2,140,152,160],"Retinal":[3],"angiomatous":[4],"proliferation":[5],"is":[6,37],"a":[7,38,74,170],"subtype":[8],"of":[9,26,41,105,117,127,134,146,150,176,184,195,201,205,229,235,244],"neovascular":[10],"age-related":[11],"macular":[12,91,249],"degeneration":[13],"(nAMD).":[14],"We":[15],"present":[16],"the":[17,52,55,62,115,209,218,230,242],"5":[18,119],"year":[19,67,118],"long":[20],"term":[21],"visual":[22,82],"and":[23,85],"anatomical":[24],"outcomes":[25],"patients":[27,44,56,99],"with":[28,32,45,121],"lesions":[30],"treated":[31,106,196],"intravitreal":[33,58],"Aflibercept.":[34],"METHODS:":[35],"This":[36],"prospective":[39],"study":[40,64,101,124,143,190],"treatment":[42],"na\u00efve":[43],"reading":[46],"centre":[47,247],"graded":[48],"lesions.":[50,232],"After":[51],"loading":[53],"phase,":[54],"received":[57],"Aflibercept":[59],"as":[60],"per":[61],"View":[63],"up":[65],"to":[66,241],"3,":[68],"thereafter":[69],"it":[70],"was":[71,94,169,207,222,237],"given":[72],"on":[73],"prn":[75],"basis.":[76],"At":[77,123,142],"each":[78],"visit,":[79],"best":[80],"corrected":[81],"acuity":[83],"(BCVA)":[84],"optical":[86],"coherence":[87],"tomography":[88],"(OCT)":[89],"central":[90,164],"thickness":[92],"(CMT)":[93],"measured.":[95],"RESULTS:":[96],"Thirty":[97],"one":[98],"reached":[100],"completion.":[102,191],"Mean":[103],"BCVA":[104,149,221,236],"eyes":[107,128,135,147,197,206,245],"had":[108,129,136,148,156,163],"decreased":[109],"by":[110],"0.6":[111],"ETDRS":[112],"letters":[113,139,159],"at":[114,189],"end":[116],"compared":[120],"baseline.":[122],"completion,":[125],"81%":[126],"stable":[130],"vision":[131],"while":[132,154,182],"19%":[133,155],"gained":[137],"15":[138,158],"more.":[141],"end,":[144],"26%":[145],"6/12":[151],"better,":[153],"lost":[157],"more":[161],"(all":[162],"foveal":[165],"photoreceptor":[166],"loss).":[167],"There":[168],"maximal":[171],"mean":[172,216],"reduction":[173],"in":[174,203,215,220],"CMT":[175],"164":[177],"microns":[178],"(p":[179],"=":[180],"<0.0001)":[181],"68%":[183],"maculae":[185],"were":[186],"fluid":[187],"free":[188],"Eighty":[192],"seven":[193],"percent":[194],"developed":[198],"nascent":[199],"GA,":[200],"which":[202],"74%":[204],"involving":[208,248],"fovea.":[210],"DISCUSSION:":[211],"Despite":[212],"initial":[213],"improvement":[214,219],"BCVA,":[217],"not":[223],"maintained":[224],"despite":[225],"good":[226],"overall":[227],"control":[228],"The":[233],"loss":[234],"most":[238],"likely":[239],"due":[240],"majority":[243],"developing":[246],"atrophy.":[250]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-02-03T00:00:00"}